Literature DB >> 28664310

Plasma levels of relaxin-2 are higher and correlated to C-peptide levels in early gestational diabetes mellitus.

Yoatzin Alonso Lopez1, Jonatan Dereke1, Mona Landin-Olsson1,2, Helena Strevens3, Charlotta Nilsson4, Magnus Hillman5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28664310     DOI： 10.1007/s12020-017-1354-x

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  14 in total

1.  Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes.

Authors:  Ravi Retnakaran; Anthony J G Hanley; Nuryt Raif; Philip W Connelly; Mathew Sermer; Bernard Zinman
Journal:  Diabetes Care       Date:  2004-03       Impact factor: 19.112

2.  The plasma levels of relaxin-2 and relaxin-3 in patients with diabetes.

Authors:  Xiaohui Zhang; Minling Zhu; Meng Zhao; Wenjia Chen; Yu Fu; Yue Liu; Wenxiu Liu; Bo Zhang; Xinhua Yin; Bing Bai
Journal:  Clin Biochem       Date:  2013-08-28       Impact factor: 3.281

3.  Plasma relaxin concentration is related to beta-cell function and insulin sensitivity in women with type 2 diabetes mellitus.

Authors:  Barbara Szepietowska; Maria Gorska; Malgorzata Szelachowska
Journal:  Diabetes Res Clin Pract       Date:  2007-11-26       Impact factor: 5.602

4.  Primary structure of the B-chain of porcine relaxin.

Authors:  C Schwabe; J K McDonald
Journal:  Biochem Biophys Res Commun       Date:  1977-03-21       Impact factor: 3.575

5.  Relaxin regulation of endometrial structure and function in the rhesus monkey.

Authors:  Laura T Goldsmith; Gerson Weiss; Smita Palejwala; Tony M Plant; Andrea Wojtczuk; W Clark Lambert; Nael Ammur; Debra Heller; Joan H Skurnick; Dean Edwards; Donna M Cole
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

6.  Maternal relaxin concentrations in diabetic pregnancy.

Authors:  B G Steinetz; P G Whitaker; J R Edwards
Journal:  Lancet       Date:  1992-09-26       Impact factor: 79.321

Review 7.  Survey by the European Board and College of Obstetrics and Gynaecology on screening for gestational diabetes in Europe.

Authors:  Katrien Benhalima; Chantal Mathieu; André Van Assche; Peter Damm; Roland Devlieger; Tahir Mahmood; Fidelma Dunne
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2016-04-11       Impact factor: 2.435

8.  Serum adiponectin in gestational diabetes and its relation to pregnancy outcome.

Authors:  M Doruk; M Uğur; A S Oruç; N Demirel; Y Yildiz
Journal:  J Obstet Gynaecol       Date:  2014-04-16       Impact factor: 1.246

9.  Influence of pregnancy on the 75-g OGTT. A prospective multicenter study. The Diabetic Pregnancy Study Group of the European Association for the Study of Diabetes.

Authors:  T Lind; P R Phillips
Journal:  Diabetes       Date:  1991-12       Impact factor: 9.461

10.  Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabetes mellitus.

Authors:  Marilyn Lacroix; Marie-Claude Battista; Myriam Doyon; Julie Ménard; Jean-Luc Ardilouze; Patrice Perron; Marie-France Hivert
Journal:  Diabetes Care       Date:  2013-01-08       Impact factor: 19.112
View more
  3 in total

1.  Relaxin-2 during pregnancy according to glycemia, continence status, and pelvic floor muscle function.

Authors:  Caroline Baldini Prudencio; Sthefanie Kenickel Nunes; Fabiane Affonso Pinheiro; Carlos Isaias Sartorão Filho; Flávia Ignácio Antônio; Guilherme Thomaz de Aquino Nava; Marilza Vieira Cunha Rudge; Angélica Mércia Pascon Barbosa
Journal:  Int Urogynecol J       Date:  2022-06-03       Impact factor: 1.932

Review 2.  Secretory products of the corpus luteum and preeclampsia.

Authors:  María M Pereira; Monica Mainigi; Jerome F Strauss
Journal:  Hum Reprod Update       Date:  2021-06-22       Impact factor: 15.610

Review 3.  Relaxin-2 in Cardiometabolic Diseases: Mechanisms of Action and Future Perspectives.

Authors:  Sandra Feijóo-Bandín; Alana Aragón-Herrera; Diego Rodríguez-Penas; Manuel Portolés; Esther Roselló-Lletí; Miguel Rivera; José R González-Juanatey; Francisca Lago
Journal:  Front Physiol       Date:  2017-08-18       Impact factor: 4.566
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.